Award

SMA Newborn Screening Kits

NHS GREATER GLASGOW AND CLYDE

This public procurement record has 2 releases in its history.

Award

02 Apr 2026 at 14:29

Award

19 Mar 2026 at 10:53

Summary of the contracting process

NHS Greater Glasgow and Clyde have concluded the award stage for the procurement of SMA Newborn Screening Kits, tailored for assessing dried blood spot samples from newborns for Spinal Muscular Atrophy (SMA). The procurement was conducted as an 'award procedure without prior publication of a call for competition', specifically under Regulation 33 due to the absence of technical competition. This process required the simultaneous screening of SMN1 deletions and SMN2 copy numbers, complying with the Scottish screening protocol organised by the National Screening Committee. The contract, valued at £237,847, was signed on 5th March 2026, with Labsystems Diagnostics OY awarded as the supplier. Located in Glasgow, this procurement falls within the industry category of laboratory reagents and was commissioned by the Scottish Newborn Screening Laboratory to support a two-year evaluation of SMA screening.

This tender offers significant opportunities for businesses involved in manufacturing laboratory reagents and diagnostics, particularly those focusing on genetic screening and newborn health. The specialised nature of the tender, emphasised by the need for screening both SMN1 and SMN2 genes, makes it ideal for businesses with advanced technical capability in molecular diagnostics. SMEs within the EU specialising in innovative diagnostic solutions stand well-positioned to engage with future contract opportunities, given the nuanced requirements and the potential to expand screening capabilities. This contract highlights the importance of adhering to national protocols and showcases the growing demand for precise genetic diagnostics in public health sectors, presenting growth avenues for businesses aligned with these criteria.

Find more tenders on our Open Data Platform.
How relevant is this notice?

Notice Title

SMA Newborn Screening Kits

Notice Description

The Scottish Newborn Screening Laboratory has been commissioned to participate in the in-service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement is to screen dried blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).

Lot Information

Lot 1

The Scottish Newborn Screening Laboratory has been commissioned to participate in the in service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement to screen died blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA). Scotland has begun a 2 year evaluation of SMA screening on behalf of the National Screening Committee to gather data to allow a decision to be made about if SMA screening should be included in the UK Newborn Screening Panel. SMA is cause by a deletion of the SMN1 gene, but the severity of the disease depends on another gene called SMN2. SMN2 is present in all babies in various copy numbers, and the lower the copy number the more severe the disease.

Procurement Information

In order to award this contract compliantly, NHSGGC will follow Regulation 33. (b)where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii)competition is absent for technical reasons.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-066e98
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/031045-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33696500 - Laboratory reagents

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£237,847 £100K-£500K

Notice Dates

Publication Date
2 Apr 2026Yesterday
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
5 Mar 20261 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS GREATER GLASGOW AND CLYDE
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
GLASGOW
Postcode
G4 0SF
Post Town
Glasgow
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM3 West Central Scotland
Small Region (ITL 3)
TLM32 Glasgow City
Delivery Location
TLM82 Glasgow City

Local Authority
Glasgow City
Electoral Ward
Dennistoun
Westminster Constituency
Glasgow North East

Supplier Information

Number of Suppliers
1
Supplier Name

LABSYSTEMS DIAGNOSTICS

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-066e98-2026-04-02T15:29:49+01:00",
    "date": "2026-04-02T15:29:49+01:00",
    "ocid": "ocds-h6vhtk-066e98",
    "description": "No other commercial kits for SMA screening include the SMN2 copy number. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. (SC Ref:828095)",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-066e98",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "SMA Newborn Screening Kits",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33696500",
            "description": "Laboratory reagents"
        },
        "mainProcurementCategory": "goods",
        "description": "The Scottish Newborn Screening Laboratory has been commissioned to participate in the in-service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement is to screen dried blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).",
        "lots": [
            {
                "id": "1",
                "description": "The Scottish Newborn Screening Laboratory has been commissioned to participate in the in service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement to screen died blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA). Scotland has begun a 2 year evaluation of SMA screening on behalf of the National Screening Committee to gather data to allow a decision to be made about if SMA screening should be included in the UK Newborn Screening Panel. SMA is cause by a deletion of the SMN1 gene, but the severity of the disease depends on another gene called SMN2. SMN2 is present in all babies in various copy numbers, and the lower the copy number the more severe the disease.",
                "hasOptions": false,
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Quality",
                            "type": "quality",
                            "description": "99"
                        },
                        {
                            "type": "price",
                            "description": "1"
                        }
                    ]
                },
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33696500",
                        "description": "Laboratory reagents"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKM82"
                    },
                    {
                        "region": "UKM82"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "In order to award this contract compliantly, NHSGGC will follow Regulation 33. (b)where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii)competition is absent for technical reasons."
    },
    "awards": [
        {
            "id": "025039-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-177780",
                    "name": "Labsystems Diagnostics OY"
                }
            ]
        },
        {
            "id": "031045-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-177780",
                    "name": "Labsystems Diagnostics OY"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-3524",
            "name": "NHS Greater Glasgow and Clyde",
            "identifier": {
                "legalName": "NHS Greater Glasgow and Clyde"
            },
            "address": {
                "streetAddress": "Procurement Department, Glasgow Royal Infirmary, 84 Castle Street",
                "locality": "Glasgow",
                "region": "UKM82",
                "postalCode": "G4 0SF",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 1412015388",
                "email": "william.cullen@nhs.scot"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "http://www.nhsggc.scot/about-us/procurement/",
                "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA10722",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-177780",
            "name": "Labsystems Diagnostics OY",
            "identifier": {
                "legalName": "Labsystems Diagnostics OY"
            },
            "address": {
                "streetAddress": "Tiilitie 3, Finlandia",
                "locality": "Vantaa",
                "region": "FI1B",
                "postalCode": "01720",
                "countryName": "Finland"
            },
            "contactPoint": {
                "telephone": "+44 358201557530",
                "email": "sales@ladsystemsdx.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-3515",
            "name": "Glasgow Sheriff Court",
            "identifier": {
                "legalName": "Glasgow Sheriff Court"
            },
            "address": {
                "streetAddress": "PO Box 23, 1 Carlton Place",
                "locality": "Glasgow",
                "postalCode": "G5 9DA",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-3524",
        "name": "NHS Greater Glasgow and Clyde"
    },
    "contracts": [
        {
            "id": "025039-2026-1",
            "awardID": "025039-2026-1",
            "status": "active",
            "value": {
                "amount": 237847,
                "currency": "GBP"
            },
            "dateSigned": "2026-03-05T00:00:00Z"
        },
        {
            "id": "031045-2026-1",
            "awardID": "031045-2026-1",
            "status": "active",
            "value": {
                "amount": 237847,
                "currency": "GBP"
            },
            "dateSigned": "2026-03-05T00:00:00Z"
        }
    ],
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000826401"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000826401"
        }
    ],
    "language": "en",
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "2",
                "measure": "smeBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "3",
                "measure": "foreignBidsFromEU",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "4",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "5",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    }
}